Inhibition of LOXL1-AS1 alleviates oxidative low-density lipoprotein induced angiogenesis via downregulation of miR-590-5p mediated KLF6/VEGF signaling pathway

References

• Schaftenaar F, Frodermann V, Kuiper J, et al. Atherosclerosis: the interplay between lipids and immune cells. Curr Opin Lipidol. 2016;27(3):209–215.
   PubMed Web of Science ®Google Scholar
• Zehr KR, Walker MK. Omega-3 polyunsaturated fatty acids improve endothelial function in humans at risk for atherosclerosis: a review. Prostaglandins Other Lipid Mediat. 2018;134:131–140.
   PubMed Web of Science ®Google Scholar
• Ishigaki Y, Katagiri H, Gao J, et al. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis. Circulation. 2008;118(1):75–83.
   PubMed Web of Science ®Google Scholar
• Mitra S, Deshmukh A, Sachdeva R, et al. Oxidized low-density lipoprotein and atherosclerosis implications in antioxidant therapy. Am J Med Sci. 2011;342(2):135–142.
   PubMed Web of Science ®Google Scholar
• Gimbrone MA Jr, García-Cardeña G. Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis. Circ Res. 2016;118(4):620–636.
   PubMed Web of Science ®Google Scholar
• Gao F, Chen J, Zhu H. A potential strategy for treating atherosclerosis: improving endothelial function via AMP-activated protein kinase. Sci China Life Sci. 2018;61(9):1024–1029.
   PubMed Web of Science ®Google Scholar
• Ferrè F, Colantoni A, Helmer-Citterich M. Revealing protein-lncRNA interaction. Brief Bioinform. 2016;17(1):106–116.
   PubMed Web of Science ®Google Scholar
• Kopp F, Mendell JT, Classification F. Experimental Dissection of Long Noncoding RNAs. Cell. 2018;172(3):393–407.
   PubMed Web of Science ®Google Scholar
• Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017;36(41):5661–5667.
   PubMed Web of Science ®Google Scholar
• Marques-Rocha JL, Samblas M, Milagro FI, et al. Noncoding RNAs, cytokines, and inflammation-related diseases. FASEB J. 2015;29(9):3595–3611.
   PubMed Web of Science ®Google Scholar
• Wang S, Yu W, Chen J, et al. LncRNA MALAT1 sponges miR-203 to promote inflammation in myocardial ischemia-reperfusion injury. Int J Cardiol. 2018;268:245.
   PubMed Web of Science ®Google Scholar
• Pan JX. LncRNA H19 promotes atherosclerosis by regulating MAPK and NF-kB signaling pathway. Eur Rev Med Pharmacol Sci. 2017;21(2):322–328.
   PubMed Web of Science ®Google Scholar
• Chen L, Yang W, Guo Y, et al. Exosomal lncRNA GAS5 regulates the apoptosis of macrophages and vascular endothelial cells in atherosclerosis. PLoS One. 2017;12(9):e0185406.
   PubMed Web of Science ®Google Scholar
• Hauser MA, Aboobakar IF, Liu Y, et al. Genetic variants and cellular stressors associated with exfoliation syndrome modulate promoter activity of a lncRNA within the LOXL1 locus. Hum Mol Genet. 2015;24(22):6552–6563.
   PubMed Web of Science ®Google Scholar
• Xue F, Xu YH, Shen CC, et al. Non-coding RNA LOXL1-AS1 exhibits oncogenic activity in ovarian cancer via regulation of miR-18b-5p/VMA21 axis. Biomed Pharmacother. 2020;125:109568.
   PubMed Web of Science ®Google Scholar
• Yang X, Xing G, Liu S, et al. LncRNA LOXL1-AS1 promotes endometrial cancer progression by sponging miR-28-5p to upregulate RAP1B expression. Biomed Pharmacother. 2020;125:109839.
   PubMed Web of Science ®Google Scholar
• Li M, Cai O, Tan S. LOXL1-AS1 drives the progression of gastric cancer via regulating miR-142-5p/PIK3CA Axis. Onco Targets Ther. 2019;12:11345–11357.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wan Q, Zhou H. Targeted-regulating of miR-515-5p by LncRNA LOXL1-AS1 on the proliferation and migration of trophoblast cells [published online ahead of print, 2020 Dec 2]. Exp Mol Pathol. 2020;118:104588.[19] Zhang L, Xie H, Li S. LncRNA LOXL1-AS1 controls osteogenic and adipocytic differentiation of bone marrow mesenchymal stem cells in postmenopausal osteoporosis through regulating the miR-196a-5p/Hmga2 axis. J Bone Miner Metab. 2020;38(6):794–805.
   PubMed Web of Science ®Google Scholar
• Catalanotto C, Cogoni C, Zardo G. MicroRNA in control of gene expression: an overview of nuclear functions. Int J Mol Sci. 2016;17(10):1712.
   PubMed Web of Science ®Google Scholar
• Yin J, Hou X, Yang S. microRNA-338-3p promotes ox-LDL-induced endothelial cell injury through targeting BAMBI and activating TGF-β/Smad pathway. J Cell Physiol. 2019;234(7):11577–11586.
   PubMed Web of Science ®Google Scholar
• Jia G, Tang Y, Deng G, et al. miR-590-5p promotes liver cancer growth and chemotherapy resistance through directly targeting FOXO1. Am J Transl Res. 2019;11(4):2181–2193.
   PubMed Web of Science ®Google Scholar
• Yu M, Luo Y, Cong Z, et al. MicroRNA-590-5p inhibits intestinal inflammation by targeting YAP. J Crohns Colitis. 2018;12(8):993–1004.
   PubMed Web of Science ®Google Scholar
• Guo Q, Su H, He JB, et al. MiR-590-5p alleviates intracerebral hemorrhage-induced brain injury through targeting Peli1 gene expression. Biochem Biophys Res Commun. 2018;504(1):61–67.
   PubMed Web of Science ®Google Scholar
• Dai Y, Zhang Z, Cao Y, et al. MiR-590-5p Inhibits Oxidized- LDL Induced Angiogenesis by Targeting LOX-1. Sci Rep. 2016;6(1):22607.
   PubMedGoogle Scholar
• DiFeo A, Martignetti JA, Narla G. The role of KLF6 and its splice variants in cancer therapy. Drug Resist Updat. 2009;12(1–2):1–7.
   PubMed Web of Science ®Google Scholar
• Kim GD, Ng HP, Patel N, et al. Kruppel-like factor 6 and miR-223 signaling axis regulates macrophage-mediated inflammation. FASEB J. 2019;33(10):10902–10915.
   PubMed Web of Science ®Google Scholar
• Goodman WA, Omenetti S, Date D, et al. KLF6 contributes to myeloid cell plasticity in the pathogenesis of intestinal inflammation. Mucosal Immunol. 2016;9(5):1250–1262.
   PubMed Web of Science ®Google Scholar
• Yu F, Witman N, Yan D, et al. Human adipose-derived stem cells enriched with VEGF-modified mRNA promote angiogenesis and long-term graft survival in a fat graft transplantation model. Stem Cell Res Ther. 2020;11(1):490.
   PubMed Web of Science ®Google Scholar
• Naito H, Iba T, Takakura N. Mechanisms of new blood-vessel formation and proliferative heterogeneity of endothelial cells. Int Immunol. 2020;32(5):295–305.
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature. 2011;473(7347):298–307.
   PubMed Web of Science ®Google Scholar
• Kwon TG, Lerman LO, Lerman A. The vasa vasorum in atherosclerosis: the vessel within the vascular wall. J Am Coll Cardiol. 2015;65(23):2478–2480.
   PubMed Web of Science ®Google Scholar
• Tang Y, Zhao J, Shen L, et al. ox-LDL induces endothelial dysfunction by promoting Arp2/3 complex expression. Biochem Biophys Res Commun. 2016;475(2):182–188.
   PubMed Web of Science ®Google Scholar
• Nègre-Salvayre A, Augé N, Camaré C, et al. Dual signaling evoked by oxidized LDLs in vascular cells. Free Radic Biol Med. 2017;106:118–133.
   PubMed Web of Science ®Google Scholar
• Chen PY, Qin L, Li G, et al. Endothelial TGF-β signalling drives vascular inflammation and atherosclerosis. Nat Metab. 2019;1(9):912–926.
   PubMedGoogle Scholar
• Moreno PR, Purushothaman KR, Sirol M, et al. Neovascularization in human atherosclerosis. Circulation. 2006;113(18):2245–2252.
   PubMed Web of Science ®Google Scholar
• Subbotin VM. Neovascularization of coronary tunica intima (DIT) is the cause of coronary atherosclerosis. Lipoproteins invade coronary intima via neovascularization from adventitial vasa vasorum, but not from the arterial lumen: a hypothesis. Theor Biol Med Model. 2012;9(1):11.
   PubMedGoogle Scholar
• Ho-Tin-Noé B, Michel JB. Initiation of angiogenesis in atherosclerosis: smooth muscle cells as mediators of the angiogenic response to atheroma formation. Trends Cardiovasc Med. 2011;21(7):183–187.
   PubMed Web of Science ®Google Scholar
• Gao L, Chen Q, Zhou X, et al. The role of hypoxia-inducible factor 1 in atherosclerosis. J Clin Pathol. 2012;65(10):872–876.
   PubMed Web of Science ®Google Scholar
• Kattoor AJ, Kanuri SH, Mehta JL. Role of Ox-LDL and LOX-1 in Atherogenesis. Curr Med Chem. 2019;26(9):1693–1700.
   PubMed Web of Science ®Google Scholar
• Singh S, Gautam AS. Upregulated LOX-1 Receptor: key player of the pathogenesis of atherosclerosis. Curr Atheroscler Rep. 2019;21(10):38.
   PubMed Web of Science ®Google Scholar
• Yuan R, Shi W, Xin Q, et al. Tetramethylpyrazine and Paeoniflorin Inhibit Oxidized LDL-Induced Angiogenesis in Human Umbilical Vein Endothelial Cells via VEGF and Notch Pathways. Evid Based Complement Alternat Med. 2018;2018:3082507.
   PubMed Web of Science ®Google Scholar
• Qiu J, Peng Q, Zheng Y, et al. OxLDL stimulates Id1 nucleocytoplasmic shuttling in endothelial cell angiogenesis via PI3K Pathway. Biochimica Et Biophysica Acta (BBA) - Mol Cell Biol Lipids. 2012;1821(10):1361–1369.
   PubMed Web of Science ®Google Scholar
• Wang L, Li G, Chen Q, et al. Octanoylated ghrelin attenuates angiogenesis induced by oxLDL in human coronary artery endothelial cells via the GHSR1a-mediated NF-κB pathway. Metab Clin Exp. 2015;64(10):1262–1271.
   PubMed Web of Science ®Google Scholar
• Zhao YH, Liu YL, Fei KL, et al. Long non-coding RNA HOTAIR modulates the progression of preeclampsia through inhibiting miR-106 in an EZH2-dependent manner [published online ahead of print, 2020 Apr 19]. Life Sci. 2020;253:117668.
   PubMed Web of Science ®Google Scholar
• Bian W, Jing X, Yang Z, et al. Downregulation of LncRNA NORAD promotes Ox-LDL-induced vascular endothelial cell injury and atherosclerosis. Aging (Albany NY). 2020;12(7):6385–6400.
   PubMedGoogle Scholar
• Yang J, Lin X, Wang LA, et al. LncRNA MALAT1 Enhances ox-LDL-Induced Autophagy through the SIRT1/MAPK/NF-κB Pathway in Macrophages [published online ahead of print, 2020 Mar 17]. Curr Vasc Pharmacol. 2020;10:2174/1570161118666200317153124.
   Google Scholar
• Zheng HK, Dong MH, Liu GH, et al. Dysregulation of the Urothelial Cancer Associated 1 Long Noncoding RNA Promotes Proliferation of Vascular Smooth Muscle Cells by Modulating Expression of P27KIP1/CDK2. Genet Test Mol Biomarkers. 2020;24(4):204–211.
   PubMed Web of Science ®Google Scholar
• Xie N, Fei X, Liu S, et al. LOXL1-AS1 promotes invasion and proliferation of non-small-cell lung cancer through targeting miR-324-3p. Am J Transl Res. 2019;11(10):6403–6412.
   PubMed Web of Science ®Google Scholar
• Gao R, Zhang R, Zhang C, et al. LncRNA LOXL1-AS1 Promotes the Proliferation and Metastasis of Medulloblastoma by Activating the PI3K/AKT Pathway. Anal Cell Pathol (Amst). 2018;2018:9275685.
   PubMedGoogle Scholar
• Liu H, Mao Z, Zhu J, et al. MiR-140-5p inhibits oxidized low-density lipoprotein-induced oxidative stress and cell apoptosis via targeting toll-like receptor 4 [published online ahead of print, 2020 Mar 12]. Gene Ther. 2020. DOI:https://doi.org/10.1038/s41434-020-0139-7.
   Google Scholar
• Li Y, Huang J, Yan H, et al. Protective effect of microRNA-381 against inflammatory damage of endothelial cells during coronary heart disease by targeting CXCR4. Mol Med Rep. 2020;21(3):1439–1448.
   PubMed Web of Science ®Google Scholar
• Yang Y, Luo H, Zhou C, et al. Regulation of capillary tubules and lipid formation in vascular endothelial cells and macrophages via extracellular vesicle-mediated microRNA-4306 transfer. J Int Med Res. 2019;47(1):453–469.
   PubMed Web of Science ®Google Scholar
• Lin J, Feng X, Zhang J, et al. Long noncoding RNA TUG1 promotes airway smooth muscle cells proliferation and migration via sponging miR-590-5p/FGF1 in asthma. Am J Transl Res. 2019;11(5):3159–3166.
   PubMed Web of Science ®Google Scholar
• Chang E, Nayak L, Jain MK. Krüppel-like factors in endothelial cell biology. Curr Opin Hematol. 2017;24(3):224–229.
   PubMed Web of Science ®Google Scholar
• Fan Y, Lu H, Liang W, et al. Krüppel-like factors and vascular wall homeostasis. J Mol Cell Biol. 2017;9(5):352–363.
   PubMed Web of Science ®Google Scholar
• Hamik A, Lin Z, Kumar A, et al. Kruppel-like factor 4 regulates endothelial inflammation. J Biol Chem. 2007;282(18):13769–13779.
   PubMed Web of Science ®Google Scholar
• Garrido-Martín EM, Blanco FJ, Roquè M, et al. Vascular injury triggers Krüppel-like factor 6 mobilization and cooperation with specificity protein 1 to promote endothelial activation through upregulation of the activin receptor-like kinase 1 gene. Circ Res. 2013;112(1):113–127.
   PubMed Web of Science ®Google Scholar
• Gallardo-Vara E, Blanco FJ, Roqué M, et al. Transcription factor KLF6 upregulates expression of metalloprotease MMP14 and subsequent release of soluble endoglin during vascular injury. Angiogenesis. 2016;19(2):155–171.
   PubMed Web of Science ®Google Scholar
• Atkins GB, Jain MK. Role of Krüppel-like transcription factors in endothelial biology. Circ Res. 2007;100(12):1686–1695.
   PubMed Web of Science ®Google Scholar
• Pan WK, Li P, Guo ZT, et al. Propranolol induces regression of hemangioma cells via the down-regulation of the PI3K/Akt/eNOS/VEGF pathway. Pediatr Blood Cancer. 2015;62(8):1414–1420.
   PubMed Web of Science ®Google Scholar
• Nasirzadeh M, Rasmi Y, Rahbarghazi R, et al. Crocetin promotes angiogenesis in human endothelial cells through PI3K-Akt-eNOS signaling pathway. EXCLI J. 2019;18:936–949. Published 2019 Oct 21
   PubMed Web of Science ®Google Scholar
• Xu X, Tian L, Zhang Z. Triptolide inhibits angiogenesis in microvascular endothelial cells through regulation of miR-92a. J Physiol Biochem. 2019;75(4):573–583.
   PubMed Web of Science ®Google Scholar